Mpox Epidemiology and Vaccine Effectiveness, England, 2023
Hannah Charles, Katie Thorley, Charlie Turner, Kirsty F. Bennet, Nick Andrews, Marta Bertran, Sema Mandal, Gayatri Amirthalingam, Mary Ramsay, Hamish Mohammed, Katy Sinka
Abstract
Reported mpox cases in England continued at a low but steady frequency during 2023. Of 137 cases reported in 2023, approximately half were acquired overseas and half were in vaccinated persons. Estimated effectiveness of 2-dose vaccine was 80%, and no vaccinated mpox patient was hospitalized.
Topics & Concepts
EpidemiologyMedicineVaccinationNew englandVirologyPediatricsEnvironmental healthInternal medicinePoliticsLawPolitical sciencePoxvirus research and outbreaksBacillus and Francisella bacterial researchZoonotic diseases and public health